Результаты поиска

Thinking Systematically About the Off-Label Use of Cancer Drugs and Combinations for Patients Who Have Exhausted Proven Therapies.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Depoliticisation, Resilience and the Herceptin Post-Code Lottery Crisis: Holding Back the Tide.

Research Highlights and Abstract This article: Covers new empirical terrain in the study of depoliticisation, with an in-depth case study of health technology regulation;Analyses depoliticisation from a novel analytical perspective, examining how depoliticised institutions are resilient to external pressure for politicisation;Posits a distinctive framework for analysing resilience, drawing on cognate literatures on policy networks and agencification;Raises interesting and distinctive questions about the nature of depoliticisation in advanced liberal democracies, arguing it is more contested th

Integrating Palliative Care into Oncology Care Worldwide: The Right Care in the Right Place at the Right Time.

Opinion statementWhile the benefits of early palliative care are indisputable, most of the current evidence has emerged from resource-rich settings in urban areas of high-income countries, with an emphasis on solid tumors in outpatient settings; this model of palliative care integration is not currently scalable internationally. A shortage of specialist palliative care clinicians means that in order to meet the needs of all patients who require support at any point along their advanced cancer trajectory, palliative care must also be provided by family physicians and oncology clinicians who req

Определение сексуальных потребностей и потребностей в интимности у пациентов с множественной миеломой: межсекторальное обследование.

ВВЕДЕНИЕ: Сексуальная дисфункция и интимная связь широко распространены в раке, однако они недооценены в гематологическая недостаточность, включая множественные миеломы (ММ). Бремя болезней MM может усугублять связанную с возрастом половую дисфункцию, однако структурированные данные по этой группе населения ограничены. Мы провели наблюдение, перекрестное, анонимное обследование среди взрослых, набранных из ММ 3 Израильские центры гематологии и израильская ассоциация пациентов ММ. В вопроснике на иврите были проанализированы области сексуальной дисфункции (до диагностирования ММ или по завершен

Double Repositioning: Veterinary Antiparasitic to Human Anticancer.

Drug repositioning, the approach of discovering different uses for existing drugs, has gained enormous popularity in recent years in the anticancer drug discovery field due to the increasing demand for anticancer drugs. Additionally, the repurposing of veterinary antiparasitic drugs for the treatment of cancer is gaining traction, as supported by existing literature. A prominent example is the proposal to implement the use of veterinary antiparasitics such as benzimidazole carbamates and halogenated salicylanilides as novel anticancer drugs. These agents have revealed pronounced anti-tumor act

Plerixafor.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Patient-reported outcome measures to detect intentional, mixed, or unintentional non-adherence to medication: a systematic review.

ObjectiveTo categorise patient-reported outcome measures (PROMs) into their propensity to detect intentional and/or unintentional non-adherence to medication, and synthesise their psychometric properties.DesignSystematic review and regression analysis.EligibilityMedication adherence levels studied at primary, secondary and tertiary care settings. Self-reported measures with scoring methods were included. Studies without proxy measures were excluded.Data sourcesUsing detailed searches with key concepts including questionnaires, reliability and validity, and restricted to English, MEDLINE, EMBAS

Proactive Identification and Digital Mental Health Intervention for the Treatment of Depression Among Individuals With Likely Incurable Cancer: A Pilot Randomized Clinical Trial.

BackgroundAlthough depression is prevalent and has significant consequences among individuals living with likely incurable cancer (ILLIC), optimal methods of identifying and treating depression in this population remain unknown.AimsTo evaluate a paradigm of (1) proactive identification (ID) (i.e., remotely and asynchronously from clinical encounters) of depression among ILLIC and (2) digital mental health intervention (DMHI) for depression treatment.MethodsIn this decentralized randomized clinical trial, ILLIC with elevated depressive symptoms were proactively identified using electronic healt

Совпадение в полном тексте источника
… J.D. is a co‐owner of Behavioral Activation Tech LLC, a small business that develops digital interventions for behavioral health treatment. Underlying intellectual property for the Moodivate intervention is owned by the University of Maryland, College Park. …

Innovations in cancer immunotherapy: chimeric antigen receptor T-cell therapy (CAR-T).

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Delivering bad news in clinical hematology: a personal perspective.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Оценка потребностей в паллиативном уходе у пациентов с повышенными хроническими условиями, не связанными с малиньяном: общий обзор инструментов оценки потребностей.

ЦЕЛИ: Пациенты с повышенными хроническими заболеваниями, не связанными с заболеваниями, испытывают бремя заболеваний и потребности в паллиативном уходе, сопоставимые с потребностями онкологических пациентов, однако паллиативная помощь часто вводится с опозданием. Определение лиц с потенциальными потребностями в паллиативном уходе является сложным делом, и, несмотря на наличие многочисленных инструментов, наиболее подходящий подход к оценке потребностей этой группы населения остается неясным. Цель этого всеобъемлющего обзора заключалась в выявлении и оценке инструментов, используемых для систем

On CAR-Ts, decentralized in-house models, and the hospital exception. Routes for sustainable access to innovative therapies.

Chimeric Antigen Receptor T cells, or CAR-Ts, are a novel class of gene and cell 'one-shot' therapies based upon collecting, reprogramming, and using patients' own immune cells to treat their cancer. The article discusses the status, prospects, and some relevant legal issues of this frontier of personalized medicine. In particular, it explores the legitimacy of 'in-house' CAR-Ts, ie treatments manufactured and delivered to patients within the same clinical center by relying upon automated cell processing systems, a decentralized model which is very different from the one currently adopted for

Quantifying hope: an EU perspective of rare disease therapeutic space and market dynamics.

Rare diseases, affecting millions globally, pose a significant healthcare burden despite impacting a small population. While approximately 70% of all rare diseases are genetic and often begin in childhood, diagnosis remains slow and only 5% have approved treatments. The UN emphasizes improved access to primary care (diagnostic and potentially therapeutic) for these patients and their families. Next-generation sequencing (NGS) offers hope for earlier and more accurate diagnoses, potentially leading to preventative measures and targeted therapies. In here, we explore the therapeutic landscape fo

Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy.

High rates of failure, exorbitant costs, and the sluggish pace of new drug discovery and development have led to a growing interest in repurposing "old" drugs to treat both common and rare diseases, particularly cancer. Cancer, a complex and heterogeneous disease, often necessitates a combination of different treatment modalities to achieve optimal outcomes. The intrinsic polygenicity of cancer, intricate biological signalling networks, and feedback loops make the inhibition of a single target frequently insufficient for achieving the desired therapeutic impact. As a result, addressing these c

The Application of Artificial Intelligence and Drug Repositioning for the Identification of Fibroblast Growth Factor Receptor Inhibitors: A Review.

Artificial intelligence talks about modeling intelligent behavior through a computer with the least human involvement. Drug repositioning techniques based on artificial intelligence accelerate the research process and decrease the cost of experimental studies. Dysregulation of fibroblast growth factor (FGF) receptors as the tyrosine kinase family of receptors plays a vital role in a wide range of malignancies. Because of their functional significance, they were considered promising drug targets for the therapy of various cancers. This review has summarized small molecules capable of inhibiting

Estimating the shares of the value of branded pharmaceuticals accruing to manufacturers and to patients served by health systems.

Previous studies have estimated that patients served by health systems accrue 59-98% of the value generated by new pharmaceuticals. This has led to questions about whether sufficient returns accrue to manufacturers to incentivize socially optimal levels of R&D. These studies have not, however, fully reflected the health opportunity costs imposed by payments for branded pharmaceuticals. We present a framework for estimating how the value generated by new branded pharmaceuticals is shared. We quantify value in net health effects and account for benefits and health opportunity costs in the patent

Developing the Breast Utility Instrument to Measure Health-Related Quality-of-Life Preferences in Patients with Breast Cancer: Selecting the Item for Each Dimension.

Introduction. Generic preference-based instruments inadequately measure breast cancer (BrC) health-related quality-of-life preferences given advances in therapy. Our overall purpose is to develop the Breast Utility Instrument (BUI), a BrC-specific preference-based instrument. This study describes the selection of the BUI items. Methods. A total of 408 patients from diverse BrC health states completed the EORTC QLQ-C30 and BR45 (breast module). For each of 10 dimensions previously assessed with confirmatory factor analysis, we evaluated data fit to the Rasch model based on global model and item

Clinical Observation and Pharmacoeconomic Evaluations of Original Research Drug and Generic Drug Bortezomib in the Treatment of Multiple Myeloma.

BackgroundMultiple myeloma (MM) is one of the hitherto incurable malignant blood tumors. Bortezomib plays an important role in the treatment of MM.ObjectiveWe aimed to compare effectiveness, safety, and pharmacoeconomic evaluations of the original research drug and the generic drug Bortezomib in the treatment of MM, so as to provide a reasonable basis for the selection of drugs in clinical diagnosis and treatment.MethodsA collection of 374 patients with MM were diagnosed and treated with combined Bortezomib in our hospital from July 2019 to January 2020.Two hundred and sixty nine cases met the

Development and definition of a simplified scoring system in patients with multiple myeloma undergoing stem cells transplantation on standard computed tomography: myeloma spine and bone damage score (MSBDS).

BackgroundIn clinical practice, there is the need to optimize imaging usage in MM patients. Accordingly, the aim of this paper was to develop a simple computed tomography (CT) scoring method for MM, able to shorten and simplify the interpretation time with good intra- and inter-reader reliability. This method, named MSBDS (Myeloma Spine and Bone Damage Score) was developed with the final aim to use standard total-body CT in the routine practice of MM centres as a complement of standard evaluations in patients undergoing stem cells transplantation.MethodsWe used a widely accepted consensus form

AI-assisted diagnosis of neuro-ophthalmic disorders: a systematic review from optic neuritis to papilledema.

BACKGROUND: Neuro-ophthalmic disorders like optic neuritis and papilledema are diagnostically challenging, with non-specific symptoms and reliance on expert interpretation of optic nerve head imaging (Liu TYA et al. J Neuroophthalmol. 41(3):368–74, 2021). Misdiagnosis can lead to severe consequences, including irreversible vision loss or failure to detect life-threatening conditions. Artificial intelligence (AI), particularly deep learning (DL), shows promise but its application in this nuanced field is not well-defined. OBJECTIVE: This systematic review evaluates the current state of AI in di